Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
screening
MedTech
Exact Sciences kicks off launch of next-gen Cologuard Plus test
Cologuard is getting an upgrade after 10 years. Exact Sciences said new genetic biomarkers in the stool DNA test have cut its rate of false positives.
Conor Hale
Mar 31, 2025 6:00am
JPM25: Guardant posts 31% sales gain as cancer blood tests grow
Jan 13, 2025 9:19am
USPSTF pushes HPV self-collection for cervical cancer screening
Dec 11, 2024 11:30am
FDA approves Exact Sciences’ next-gen Cologuard Plus home test
Oct 4, 2024 12:30pm
Exact Sciences presents early colorectal cancer blood test data
Sep 16, 2024 11:30am
FDA approves Guardant’s colorectal cancer screening blood test
Jul 29, 2024 11:00am